Research Patents

 
Stock Quotes for Research Patents top ^
  • Industry: Business Services
  • Sector: Industrials
  • Stock Style: Small Value
  • Stock Type: Cyclical
Sign-up for ptnt investment picks

 
News Articles for Research Patents top ^
2014/5/23
NEW YORK , May 23, 2014 /PRNewswire/ -- Network-1 Technologies, Inc. (OTC BB: NTIP) today announced that the Patent Trial and Appeal Board ("PTAB") of the United States Patent and Trademark Office ("USPTO") issued its decision in favor of Network-1 in the pending Inter Partes Review ("IPR") rejecting a challenge to the patentability of Network-1's Remote Power Patent (U.S Patent No.
Sign-up for U.S. Patent Trial and Appeal Board Rules in Favor of Network-1 in Pending Inter Partes Review investment picks
First of a series of tools enabling public access to actionable patent market data and intelligence SAN FRANCISCO , May 12, 2014 /PRNewswire/ -- RPX Corporation (NASDAQ: RPXC) , the leading provider of patent risk management solutions, today launched RPX Search, the first search engine to provide public access to the most complete database that connects patent, litigation, and entity data in one resource.
Sign-up for RPX Launches Free Search Engine for All Patent, Litigation, and Entity Information investment picks
The following letter I have written and sent directly to Mr.
Sign-up for Open Letter to Hussein Enan and the Board of Internet Patents Corp. investment picks
Company Controls Significant, Industry First Patent; Covers System for Identity Verification, Monitoring, and Development of Medicine in Marijuana Businesses LOS ANGELES , May 16, 2014 Medbox, Inc. (OTCQB: MDBX) ( www.medbox.com ), a leader in providing ancillary services to the alternative medicine industry, dispensary consulting services, and patented medicine dispensing systems to medical and retail industries, today announced that the US Patent and Trademark Office (USPTO) has issued a notice of allowance on what company executives describe as the first "Seed-to-Sale" patent the marijuana industry has ever seen.
Sign-up for Medbox Granted Exclusive License on To Be Issued "Seed-to-Sale" Marijuana Monitoring Patent investment picks
Hull recognized by the European Patent Office for his groundbreaking invention of the original 3D printing technology Stereolithography (SLA ® ) EPO people's choice award voting now active through June 10, 2014 Inducted into the National Inventor's Hall of Fame in partnership with the United States Patent and Trademark Office for his globally impactful and transformative work inventing and pioneering 3D printing ROCK HILL, S.C., May 15, 2014 (GLOBE NEWSWIRE) -- 3D Systems (NYSE:DDD) today announced that Chuck Hull, the inventor of 3D printing and founder of 3D Systems, has been nominated by the European Patent Office (EPO) for the 2014 European Inventor Award .
Sign-up for Photo Release -- 3D Systems' Founder Chuck Hull Nominated by European Patent Office for 2014 Award investment picks
STUART, Fla., May 22, 2014 (GLOBE NEWSWIRE) -- Ecosphere Technologies, Inc. (OTCBB:ESPH) , a U.S. technology licensing and innovative manufacturing company, today announced that the U.S. Patent and Trademark Office has issued a formal Notice of Allowance for Patent # 8,721,898 which is a process patent for lowering the scaling tendencies in flowback water used in the exploration and production of oil and natural gas wells.
Sign-up for Ecosphere Technologies Receives 7th U.S. Patent to Eliminate Scaling Chemicals for Hydraulic Fracturing Oil and Gas Wells investment picks
LAVAL, Quebec, April 24, 2014 (GLOBE NEWSWIRE) -- Neptune Technologies & Bioressources Inc. ("Neptune" or the "Corporation") (Nasdaq:NEPT) (TSX:NTB), announced today that the U.S. Patent & Trademark Office (the "USPTO") has granted Neptune a new continuation patent (U.S. Patent No.
Sign-up for Neptune Obtains New US Patent Relating to Treatment of Alzheimer's investment picks
http://media.marketwire.com/attachments/200709/365332_biologo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1114617&ProfileId=051205&sourceType=1 IRVINE, CA --
Sign-up for BIOLASE Wins Patent Infringement Case in Germany investment picks
ALPHARETTA, Ga., May 12, 2014 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (OTCBB:SNWV) has received a patent issued by the U.S. Patent and Trademark Office entitled "Methods and Devices for Cleaning and Sterilization with Shock Waves." The claims of the patent (patent number 8,685,317) relate to the use of shock waves to clean and sterilize fluids in containers and/or pipes.
Sign-up for SANUWAVE Receives U.S. Patent for Cleaning and Sterilization of Fluids and Food Liquids With Shock Waves investment picks
ALPHARETTA, Ga., May 20, 2014 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (OTCBB:SNWV) today received a patent issued by the U.S. Patent and Trademark Office entitled "Use of Pressure Waves for Stimulation, Proliferation, Differentiation and Post-Implantation Viability of Stem Cells." The claims of the patent (patent number 8,728,809) relate to the use of shock waves for stimulation of proliferation inside the body of donor stem cells.
Sign-up for SANUWAVE Receives U.S. Patent for Stem Cell Treatments Using Shock Wave Technology investment picks
LAVAL, Quebec, April 27, 2014 (GLOBE NEWSWIRE) -- Neptune Technologies & Bioressources Inc. (" Neptune ") (Nasdaq:NEPT) (TSX:NTB) and Acasti Pharma Inc. (" Acasti ") (Nasdaq:ACST) (TSX-V:APO), a Neptune subsidiary, announce that a final and binding patent infringement settlement and license agreement has been signed with Enzymotec Ltd.
Sign-up for Neptune and Enzymotec Conclude Final Patent Infringement Settlement ad License Agreement investment picks
BERKELEY HEIGHTS, N.J., May 5, 2014 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) (Cyclacel or the Company), today announced that the Japanese Patent and Trademark Office issued two patents broadening the exclusivity of sapacitabine, the Company's lead clinical candidate.
Sign-up for New Japanese Patents Issued Covering Sapacitabine Pharmaceutical Formulations and Combination Treatments investment picks
2014/5/12
Valeant Pharmaceuticals Enters Into Patent Settlement Agreements With Actavis Canada NewsWire LAVAL, Quebec , May 12, 2014 /CNW/ - Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) announced today that certain of its subsidiaries have entered into settlement agreements with affiliates of Actavis plc related to Actavis' generic versions of Acanya® Gel, 1.2%/2.5%, and Tiazac ® XC.
Sign-up for Valeant Pharmaceuticals Enters Into Patent Settlement Agreements With Actavis investment picks
NEW YORK, May 15, 2014 (GLOBE NEWSWIRE) -- Elray Resources Inc. (OTCBB:ELRAD), announced it will file a Provisional Patent Application for its SimRacing virtual horse racing product.
Sign-up for Elray Gaming to Submit a Patent Application for Its SimRacing Virtual Horse Racing Product investment picks
2014/5/21
MIAMI and WEST PALM BEACH, Fla.
Sign-up for netTALK Prevails in Patent Reexamination by the United States Patent and Trademark Office Patent Enforcement Litigation Resumes investment picks
2014/5/21
DALLAS , May 21, 2014 /PRNewswire/ -- TransData Inc., a leading manufacturer of advanced solid-state electricity meters, announced today that it has licensed three of its wireless "Smart Meter Patents" to Sensus USA Inc. The terms of the agreement, which licenses Patent Nos.
Sign-up for TransData Licenses Wireless Electric Meter Patents to Sensus USA Inc. investment picks
AUSTIN, Texas, May 1, 2014 (GLOBE NEWSWIRE) -- 1 st Detect Corporation, a subsidiary of Astrotech Corporation (Nasdaq:ASTC) , announced today that the United States Patent Office ("USPTO") has allowed the issuance of a key patent for the company's unique ion trap used for chemical analysis and detection.
Sign-up for 1st Detect Awarded U.S. Patent for End Cap Voltage Control of Ion Traps investment picks
TAMPA, Fla., April 25, 2014 (GLOBE NEWSWIRE) -- via PRWEB - MagneGas Corporation, ("MagneGas" or the "Company") (NASDAQ: MNGA) , a technology company that counts among its inventions a patented process that converts liquid waste into a hydrogen-based fuel, announced today that it filed a provisional patent protecting new methods of applying MagneGas® to waste incineration through a primary heating process and secondary burning method.
Sign-up for MagneGas Corporation Files Provisional Patent to Improve Waste Incineration Process investment picks
DALLAS, April 24, 2014 (GLOBE NEWSWIRE) -- Blue Calypso, Inc. (OTCBB:BCYP) , a developer of digital innovation products and services, has received written notice that the United States Court of Appeals for the Federal Circuit has denied Groupon's (Nasdaq:GRPN) petition for mandamus to transfer the patent infringement case out of the Eastern District of Texas.
Sign-up for Blue Calypso Announces That Federal Circuit Denies Groupon's Petition for Transfer of Patent Infringement Case investment picks

Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Research Patents
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry

Previous: Research Partnership  |  Next: Research Permit